Objective: Inflammatory bowel diseases are idiopathic inflammatory disorders of the gastrointestinal tract. Chronic inflammation that occurs in the colon can develop into colon cancer. Lunasin has been known to resist inflammatory reactions induced by lipopolysaccharide in vitro. The role of lunasin as anti-inflammatory in vivo is not widely known. In this study, we analyzed the effect of lunasin from Indonesian soybean to decrease the risk of inflammation by analyzing the expressions of inducible nitric oxide synthase (iNOS) and β-catenin. Methods: A total of 30 mice are divided into six groups. Normal group was not induced by dextran sodium sulfate (DSS). The other groups were induced by DSS 2% through drinking water for 9 days. After 9 days, negative group did not receive any treatment, besides the other groups received treatment given lunasin dose 20 mg/kg BB and 40 mg/kg BB, commercial lunasin, and positive given aspirin. Treatment was performed for 5 weeks. Immunohistochemistry scores of iNOS and β-catenin proteins were analyzed using statistical tests. Results: Expression of iNOs decreased significantly (p<0.05) with an average score of 60.134 and 35.473. Expression of β-catenin decreased significantly (p<0.05) with an average score of 15.58 and 11.131. Conclusion: Lunasin dose 20 mg/kg BW and 40 mg/kg BB were able to inhibit inflammation by decreasing the expressions of iNOS, and β-catenin.
|Number of pages||5|
|Journal||Asian Journal of Pharmaceutical and Clinical Research|
|Publication status||Published - 1 Jan 2018|
- Inducible nitric oxide synthase